Tilray Brands, Inc. (TLRY.TO)

2.000.05 (2.56%)

Tilray Brands, Inc. (TLRY.TO) stock comprehensive Forecast and Price Target with Analyst Ratings, Revenue Estimates, and complete financial and advanced discounted cashflow forecasts for up to 10 years.

High Bankruptcy RiskFair ValuationLow ProfitabilityAdequate Financial HealthModerate EfficiencyModerate GrowthLow QualityAdequate Dividend ProfileIndustry Rank: 44.14%Sector Rank: 55.17%

TSX - Healthcare - Drug Manufacturers - Specialty & Generic | Market Cap: 2.20B | Next Earnings Date: 9 Oct 2025

Day's Range

1.90 - 2.15

52-Week Range

0.48 - 2.54

Volume

9.88M / 3.06M (Avg.)

P/E Ratio | EPS

-0.59 | -3.40

Trending:

Analyst Consensus

Compare with Competitor

None WEED.TO ACB.TO TLRY OGI.TO CRON.TO

View analysts' price targets and recommendations, and compare them with competitors.

Analyst Price Target

No Data

No price target data available for this metric.

Analyst Recommendation

Hold

Positive consensus among analysts.

Financial Forecasts for May 2028

Select Date

May 2030 May 2029 May 2028 May 2027 May 2026 May 2025

Compare with Competitor

None WEED.TO ACB.TO TLRY

Analyze analyst forecasts for the company and compare them with competitors.

Estimated Revenue

1.54B

Increased from previous period

Low: 1.47B | High: 1.64B

The estimated revenue has increased from the previous period.

Estimated EBITDA

-603.99M

Decreased from previous period

Low: -640.33M | High: -575.80M

The estimated EBITDA has decreased from the previous period.

Estimated EPS

0.04

Increased from previous period

Low: 0.04 | High: 0.05

The estimated EPS has increased from the previous period.

Estimated Net Income

32.05M

Increased from previous period

Low: 30.10M | High: 34.55M

The estimated net income has increased from the previous period.

Estimated EBIT

-743.77M

Decreased from previous period

Low: -788.53M | High: -709.05M

The estimated EBIT has decreased from the previous period.

Estimated SG&A Expense

510.99M

Increased from previous period

Low: 487.13M | High: 541.74M

The estimated SG&A expenses have increased from the previous period.

Select Metric for Chart

Discounted Cash Flow Forecasts for 2020

Select Year

2030 2029 2028 2027 2026 2025

Compare with Competitor

None OGI.TO HEXO.TO CRON.TO

Analyze DCF forecasts for the company and compare them with competitors.

Revenue

563.89M

No previous data to compare.

Revenue Growth Rate

No Data

No DCF data available for this metric in the selected year.

EBITDA

-26.53M

No previous data to compare.

EBITDA Margin

-4.71%

No previous data to compare.

EBIT

-49.15M

No previous data to compare.

EBIT Margin

-8.72%

No previous data to compare.

Depreciation

22.61M

No previous data to compare.

Total Cash

516.98M

No previous data to compare.

Cash as Percentage of Revenue

91.68%

No previous data to compare.

Receivables

82.21M

No previous data to compare.

Receivables as Percentage of Revenue

14.58%

No previous data to compare.

Inventories

274.82M

No previous data to compare.

Inventories as Percentage of Revenue

48.74%

No previous data to compare.

Accounts Payable

59.36M

No previous data to compare.

Payables as Percentage of Revenue

10.53%

No previous data to compare.

Capital Expenditure

-137.69M

No previous data to compare.

CapEx as Percentage of Revenue

-24.42%

No previous data to compare.

Weighted Average Cost of Capital (WACC)

14.26%

No previous data to compare.

Cost of Equity

14.92%

No previous data to compare.

Cost of Debt

12.72%

No previous data to compare.

Beta

2.19

No previous data to compare.

Diluted Shares Outstanding

742.65M

No previous data to compare.

Total Debt

558.58M

No previous data to compare.

Total Equity

1.30B

No previous data to compare.

Total Capital

1.86B

No previous data to compare.

Debt Weighting

30.06%

No previous data to compare.

Equity Weighting

69.94%

No previous data to compare.

EBIAT

-51.53M

No previous data to compare.

Unlevered Free Cash Flow

-464.28M

No previous data to compare.

Long-Term Growth Rate

2.00%

No previous data to compare.

Terminal Value

-11.86B

No previous data to compare.

Enterprise Value

-9.54B

No previous data to compare.

Net Debt

229.28M

No previous data to compare.

Equity Value

-9.77B

No previous data to compare.

Equity Value Per Share

-13.15

No previous data to compare.

Select Metric for Chart

Discounted Cash Flow Forecasts for 2020

Select Year

2030 2029 2028 2027 2026 2025

Compare with Competitor

None OGI.TO HEXO.TO CRON.TO

Analyze DCF forecasts for the company and compare them with competitors.

Revenue

563.89M

No previous data to compare.

Revenue Growth Rate

No Data

No DCF data available for this metric in the selected year.

EBITDA

-26.53M

No previous data to compare.

EBITDA Margin

-4.71%

No previous data to compare.

EBIT

-49.15M

No previous data to compare.

EBIT Margin

-8.72%

No previous data to compare.

Depreciation

22.61M

No previous data to compare.

Total Cash

516.98M

No previous data to compare.

Cash as Percentage of Revenue

91.68%

No previous data to compare.

Receivables

82.21M

No previous data to compare.

Receivables as Percentage of Revenue

14.58%

No previous data to compare.

Inventories

274.82M

No previous data to compare.

Inventories as Percentage of Revenue

48.74%

No previous data to compare.

Accounts Payable

59.36M

No previous data to compare.

Payables as Percentage of Revenue

10.53%

No previous data to compare.

Capital Expenditure

-137.69M

No previous data to compare.

CapEx as Percentage of Revenue

-24.42%

No previous data to compare.

Weighted Average Cost of Capital (WACC)

14.26%

No previous data to compare.

Cost of Equity

14.92%

No previous data to compare.

Cost of Debt

12.72%

No previous data to compare.

Beta

2.19

No previous data to compare.

Diluted Shares Outstanding

742.65M

No previous data to compare.

Total Debt

558.58M

No previous data to compare.

Total Equity

1.30B

No previous data to compare.

Total Capital

1.86B

No previous data to compare.

Debt Weighting

30.06%

No previous data to compare.

Equity Weighting

69.94%

No previous data to compare.

EBIAT

-51.53M

No previous data to compare.

Unlevered Free Cash Flow

-464.28M

No previous data to compare.

Long-Term Growth Rate

2.00%

No previous data to compare.

Terminal Value

-11.86B

No previous data to compare.

Enterprise Value

-9.54B

No previous data to compare.

Net Debt

229.28M

No previous data to compare.

Equity Value

-9.77B

No previous data to compare.

Equity Value Per Share

-13.15

No previous data to compare.

Select Metric for Chart